Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Rohit Aggarwal, MD, MS
University of Pittsburgh
Pittsburgh, PA, United States
Disclosure(s): Actigraph: Consultant (Ongoing); Alexion: Consultant (Ongoing); ANI Pharmaceuticals: Consultant (Ongoing); Argenx: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); CabalettaBio: Consultant (Ongoing); Capella Bioscience: Consultant (Ongoing); Corbus: Consultant (Ongoing); CSL Behring: Consultant (Ongoing); EMD Serono: Consultant (Ongoing), Grant/Research Support (Ongoing); Galapagos: Consultant (Ongoing); Horizon Therapeutics: Consultant (Ongoing); I-Cell: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Kezar: Consultant (Ongoing); Kyverna: Consultant (Ongoing); Mallinckrodt: Grant/Research Support (Ongoing); Merck: Consultant (Ongoing); Octapharma: Consultant (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Q32: Grant/Research Support (Ongoing); Roivant: Consultant (Ongoing); Sanofi: Consultant (Ongoing); Teva: Consultant (Ongoing)
Lorenzo Cavagna, MD
University of Pavia and Fondazione IRCCS Policlinico San Matteo Hospital of Pavia
Pavia, Pavia, Italy
Disclosure(s): No financial relationships with ineligible companies to disclose
Erin Wilfong, MD, PhD (she/her/hers)
Vanderbilt University Medical Center
Nashville, TN, United States
Disclosure(s): Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cabaletta Bio: Advisor or Review Panel Member (Ongoing)
This session is aimed to improve the clinical approach and management of patients with anti-synthetase syndrome, in particular ruling out mimickers and managing progressive interstitial lung disease (ILD). It will also highlight the international effort to propose a preliminary classification of anti-synthetase syndrome.
Speaker: Lorenzo Cavagna, MD – University of Pavia and Fondazione IRCCS Policlinico San Matteo Hospital of Pavia
Speaker: Erin Wilfong, MD, PhD (she/her/hers) – Vanderbilt University Medical Center
Speaker: Rohit Aggarwal, MD, MS – University of Pittsburgh